PF-06882961
CAS No. 2230198-02-2
PF-06882961( —— )
Catalog No. M22917 CAS No. 2230198-02-2
PF-06882961 is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist. PF-06882961 shows mild to moderate damage to the heart, moderate to severe effects on the thymus gland (which helps with managing infection), mild to moderate stomach ulcers at the highest dose level given in the rat.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 105 | In Stock |
|
| 5MG | 86 | In Stock |
|
| 10MG | 150 | In Stock |
|
| 25MG | 198 | In Stock |
|
| 50MG | 247 | In Stock |
|
| 100MG | 425 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePF-06882961
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-06882961 is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist. PF-06882961 shows mild to moderate damage to the heart, moderate to severe effects on the thymus gland (which helps with managing infection), mild to moderate stomach ulcers at the highest dose level given in the rat.
-
DescriptionPF-06882961 is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist. PF-06882961 shows mild to moderate damage to the heart, moderate to severe effects on the thymus gland (which helps with managing infection), mild to moderate stomach ulcers at the highest dose level given in the rat.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetGlucagon Receptor
-
RecptorGLP-1
-
Research AreaMetabolism
-
IndicationDiabetes Mellitus, Type 2
Chemical Information
-
CAS Number2230198-02-2
-
Formula Weight555.6
-
Molecular FormulaC31H30FN5O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (224.98 mM; Need ultrasonic)
-
SMILESOC(C1=CC=C(N=C(CN2CCC(C3=NC(OCC4=CC=C(C#N)C=C4F)=CC=C3)CC2)N5C[C@H]6OCC6)C5=C1)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. 20th SCI/RSC Medicinal Chemistry Symposium.
molnova catalog
related products
-
GRA Ex-25
A potent glucagon receptor inhibitor with IC50 of 56 and 55 nM for rat and human glucagon receptors.
-
Glucagon-like peptid...
Glucagon-like peptide 1 (1-37), human is a highly potent agonist of the GLP-1 receptor.Pancreatic hormone synthesized by post-translational processing of proglucagon. Unlike truncated forms of GLP-1, it has no effect on food intake in rats and does not enhance pancreatic insulin secretion.
-
Oxyntomodulin (porci...
GLP-1 receptor agonist. Endogenous preproglucagon-derived neuropeptide that modulates feeding and metabolism. Also secreted by intestinal L-cells. Increases cAMP production and inhibits gastric acid secretion in rat stomach. Also weak glucagon receptor agonist.
Cart
sales@molnova.com